Treatment of priapism in pediatric patients with sickle cell disease

American Journal of Health-System Pharmacy

Volumn 61, Issue 4, 2004, Pages 355-363

  Maples, Brandon L ^a   Hagemann, Tracy M ^b,c  

^a Walgreens   (United States)

^b UOCP   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF PHARMACY   (United States)

Author keywords

Analgesics and antipyretics; Antineoplastic agents; Diethylstilbestrol; Estrogens; Gonadotropin releasing hormone agonists; Hydration; Hydroxyurea; Patient information; Pediatrics; Priapism; Sympathomimetic agents

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; ANTINEOPLASTIC AGENT; ANTIPYRETIC ANALGESIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIETHYLSTILBESTROL; ESTROGEN; ETILEFRINE; FLUTAMIDE; GONADORELIN DERIVATIVE; GOSERELIN; HYDRALAZINE; HYDROXYUREA; KETAMINE; LEUPRORELIN; METARAMINOL; METHYLENE BLUE; PENTOXIFYLLINE; PETHIDINE; PHENYLEPHRINE; PHENYLPROPANOLAMINE; PHYSOSTIGMINE; PROSTAGLANDIN E1; PSEUDOEPHEDRINE; TERBUTALINE; UNINDEXED DRUG; VERAPAMIL;

ABDOMINAL CRAMP; ABSCESS; ACNE; ADOLESCENT; ADULT; ANALGESIA; ANEMIA; ANOREXIA; BODY WEIGHT DISORDER; BONE MARROW SUPPRESSION; BREAST TENDERNESS; CEREBROVASCULAR DISEASE; CHILD; CHILDHOOD DISEASE; CHILL; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONSTIPATION; DIARRHEA; DIZZINESS; EDEMA; ERECTILE DYSFUNCTION; ERYTHEMA; EXERCISE; FEVER; FLUID INTAKE; GASTROINTESTINAL SYMPTOM; GYNECOMASTIA; HEADACHE; HEART PALPITATION; HEMATOMA; HIRSUTISM; HUMAN; INJECTION PAIN; KIDNEY DYSFUNCTION; LEUKOPENIA; LIBIDO DISORDER; MALAISE; MICTURITION; NAUSEA; PATIENT EDUCATION; PRIAPISM; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RASH; REVIEW; SEXUAL BEHAVIOR; SHUNTING; SICKLE CELL ANEMIA; SIDE EFFECT; SOCIAL ASPECT; STOMATITIS; TESTIS ATROPHY; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT PLANNING; VOMITING; MALE;

ANEMIA, SICKLE CELL; CHILD; HUMANS; MALE; PRIAPISM;

EID: 1642484971     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.4.355     Document Type: Review

References (28)

1. Mantadakis E, Cavender JD, Rogers ZR et al. Prevalence of priapism in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol. 1999; 21:518-22.
2. Bruno D, Wigfall DR, Zimmerman SA et al. Genitourinary complications of sickle cell disease. J Urol. 2001; 166:803-11.
3. Harmon WJ, Nehra A. Priapism: diagnosis and management. Mayo Clin Proc. 1997; 72:350-5.
4. Ramos CE, Park JS, Ritchey ML et al. High flow priapism associated with sickle cell disease. J Urol. 1995; 153:1619-21.
5. Rudick DH. Successful treatment of arterial priapism with alpha-agonist irrigation: a rural experience. J Urol. 2002; 167:2132. Case report.
6. Powars DR, Johnson CS. Priapism. Hematol Oncol Clin North Am. 1996; 10:1363-72.
7. Mantadakis E, Ewalt DH, Cavender JD et al. Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism. Blood. 2000; 95:78-82.
8. Molina L, Bejany D, Lynne CM et al. Diluted epinephrine solution for the treatment of priapism. J Urol. 1989; 141:1127-8.
9. Gbadoe AD, Atakouma Y, Kusiaku K et al. Management of sickle cell priapism with etilefrine. Arch Dis Child. 2001; 85:52-3.
10. Virag R, Bachir D, Lee K et al. Preventive treatment of priapism in sickle cell disease with oral and self-administered intracavernous injection of etilefrine. Urology. 1996; 47:777-81.
11. Lowe FC, Jarow JP. Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin El-induced prolonged erections. Urology. 1993; 42:51-3.
12. Ahmed I, Shaikh NA. Treatment of intermittent idiopathic priapism with oral terbutaline. Br J Urol. 1997; 80:341.
13. Shantha TR, Finnerty DP, Rodriquez AP. Treatment of persistent penile erection and priapism using terbutaline. J Urol. 1989; 141:1427-9.
14. Govier FE, Jonsson E, Kramer-Levien D. Oral terbutaline for the treatment of priapism. J Urol. 1994; 151:878-9.
15. Lupron Depot-Ped package insert. Lake Forest, IL: TAP Pharmaceuticals; 2000 Mar.
16. Levine LA, Guss SP. Gonadotropin-releasing hormone analogues in the treatment of sickle cell anemia-associated priapism. J Urol. 1993; 150(2, pt. 1):475-7.
17. Steinberg J, Eyre RC. Management of recurrent priapism with epinephrine self-injection and gonadotropin-releasing hormone analogue. J Urol. 1995; 153:152-3.
18. Serjeant GR, de Ceulaer K, Maude GH. Stilboestrol and stuttering priapism in homozygous sickle-cell disease. Lancet. 1985; 2:1274-6.
19. Gbadoe AD, Assimadi JK, Segbena YA. Short period of administration of diethylstilbestrol in stuttering priapism in sickle cell anemia. Am J Hematol. 2002; 69:297-8. Letter.
20. Mosby's drug consult. Diethylstilbestrol drug monograph. http:/home.mdconsult.com/das/drug/view/22298733/1/1055/top?sid=131167708 (accessed 2002 Sep 25).
21. Al Jam'a AH, Al Dabbous IA. Hydroxyurea in the treatment of sickle cell associated priapism. J Urol. 1998; 159:1642. Case report.
22. Hydrea package insert. Princeton, NJ: Bristol-Myers Squibb; 2000 Jan.
23. Ravindran RS, Dryden GE, Somerville GM. Treatment of priapism with ketamine and physostigmine. Anesth Analg. 1982; 61:705-7.
24. Baruchel S, Rees J, Bernstein ML et al. Relief of sickle cell priapism by hydralazine. Report of a case. Am J Pediatr Hematol Oncol. 1993; 15:115-6.
25. Martinez-Portillo F, Hoang-Boehm J, Weiss J et al. Methylene blue as a successful treatment alternative for pharmacologically induced priapism. Eur Urol. 2001; 39:20-3.
26. Steers WD, Selby JB. Use of methylene blue and selective embolization of the pudendal artery for high flow priapism refractory to medical and surgical treatments. J Urol. 1991; 146:1361-3.
27. Mejean A, Marc B, Rigot JM et al. Re: use of methylene blue and selective embolization of the pudendal artery for high flow priapism refractory to medical and surgical treatments. J Urol. 1993; 149:1149. Letter.
28. Hamre MR, Harmon EP, Kirkpatrick DV et al. Priapism as a complication of sickle cell disease. J Urol. 1991; 145:1-5.